Coronary Heart Disease
📧 Sign up to get email alerts when something new happens for Coronary Heart Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease. [Phase 2]
Phase IIa clinical trial of TSG-01 in chronic heart failure due to coronary heart disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-18Clinical Trial Update: High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV [Phase 2]
A Phase 2 clinical trial evaluated high intensity lipid lowering in people living with HIV after acute coronary syndromes; status completed …
-
FDA approval · 2022-08-29FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin from NorthStar Rx LLC under the ANDA framework, supporting continued regulatory stat…
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: HuoXin Pills Intervention on Patients With Coronary Heart Disease After Drug-Coated Balloon Implantation [Phase 4]
Phase 4 trial update evaluating HuoXin Pills for patients with coronary heart disease after drug-coated balloon implantation.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Digital Flu Intervention for People With Cardiovascular Conditions [NA]
A completed clinical trial evaluating a digital flu intervention for people with cardiovascular conditions, with results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: A Randomized Controlled Trial of Stress Reduction on Cardiovascular Morbidity and Mortality in African Americans [Phase 2]
Phase 2 randomized trial evaluating stress reduction and its effects on cardiovascular morbidity and mortality in African Americans with cor…
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease [Phase 4]
Phase 4 trial update evaluating the effect of pioglitazone on insulin resistance, atherosclerosis progression, and clinical course of corona…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032) [Phase 3]
Phase 3 long-term safety and tolerability study of ezetimibe plus atorvastatin in patients with coronary heart disease, multiple risk factor…
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740) [Phase 4]
Phase 4 trial evaluating the effectiveness and safety of adding ezetimibe to atorvastatin in patients with high cholesterol and coronary hea…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE) [NA]
A completed clinical trial update (TOPCARE) investigating obesity management to optimize health in cardiac rehabilitation; results posted in…
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Evaluate the Efficacy and Safety of MUSK Pill on Coronary Microvascular Dysfunction [Phase 4]
Phase 4 trial evaluating MUSK Pill for coronary microvascular dysfunction with angina-related conditions; efficacy and safety data are curre…
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study [NA]
Clinical trial update for the CAPITAL iRADIAL study evaluating a smartphone app to assess radial artery patency in coronary heart disease.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction [Phase 4]
Phase 4 trial investigating the effect of nicorandil on cardiac sympathetic nerve activity in patients with acute myocardial infarction pres…
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Rivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCI [Phase 4]
Phase 4 clinical trial update comparing rivaroxaban and aspirin in patients with CHD and GD undergoing PCI.
-
FDA approval · 2021-03-15FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pravastatin sodium to allow Aurobindo Pharma Limited to market a generic pravastatin product in …
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Comparison Between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes Following Cardiac Surgery [Phase 4]
A Phase 4 clinical trial comparing propofol versus inhalational anesthetic agents to assess cardiovascular outcomes after cardiac surgery; s…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD) [Phase 4]
Phase 4 trial update on atorvastatin for high cholesterol in patients at high risk of coronary heart disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris [Phase 4]
Phase 4 trial update on Wen Xin Granules for unstable angina within coronary heart disease, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR) [NA]
A completed clinical trial (CIRT-CFR) assessing coronary flow reserve for cardiovascular inflammation in coronary heart disease and metaboli…
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD) [Phase 1, Phase 2]
Phase 1/2 trial update on APL180 assessing safety and efficacy in healthy volunteers and patients with Coronary Heart Disease.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril
A completed clinical trial evaluating the efficacy and tolerability of a fixed-dose combination of bisoprolol and perindopril for arterial h…
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris [Phase 4]
Phase 4 trial update evaluating efficacy and safety of Xueshuanxinmaining Tablet for stable angina in coronary heart disease.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris [Phase 4]
Phase 4 trial update on Yangxin Shengmai Granules for stable angina in coronary heart disease, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) [Phase 3]
Phase 3 clinical trial update for a sirolimus-eluting stent (MiStent System) evaluating efficacy and safety in coronary heart disease.
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection [NA]
Completed clinical trial studying alternate day fasting for weight loss, weight maintenance, and cardio-protection in individuals with coron…